glp-1 pathophysiology Receptor Agonists as Treatments for Type 2 Diabetes glp-1_analogs [TUSOM | Pharmwiki]
Description
Theres no standard of care or gold standard on how to wean right now, said Allison Adams, an obesity and internal medicine doctor with UK HealthCare in Kentucky
![glp-1 pathophysiology Receptor Agonists as Treatments for Type 2 Diabetes glp-1_analogs [TUSOM | Pharmwiki]](https://tmedweb.tulane.edu/pharmwiki/lib/exe/fetch.php/glp1.png?w=600&tok=baf39c)
Compounded drugs are not FDA-approved and are not evaluated for safety or efficacy by the FDA
![glp-1 pathophysiology Receptor Agonists as Treatments for Type 2 Diabetes glp-1_analogs [TUSOM | Pharmwiki]](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fnrneph.2017.123/MediaObjects/41581_2017_Article_BFnrneph2017123_Fig1_HTML.jpg)
Clinical eligibility, dosing, and prescription protocol stay identical regardless of how the brand is spelled in the search bar
Kosinski, M
![glp-1 pathophysiology Receptor Agonists as Treatments for Type 2 Diabetes glp-1_analogs [TUSOM | Pharmwiki]](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41574-018-0016-2/MediaObjects/41574_2018_16_Fig1_HTML.jpg)
Let the people say what they will.
Demand for GLP-1s has skyrocketed